GR3030614T3 - INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS - Google Patents

INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS

Info

Publication number
GR3030614T3
GR3030614T3 GR990401699T GR990401699T GR3030614T3 GR 3030614 T3 GR3030614 T3 GR 3030614T3 GR 990401699 T GR990401699 T GR 990401699T GR 990401699 T GR990401699 T GR 990401699T GR 3030614 T3 GR3030614 T3 GR 3030614T3
Authority
GR
Greece
Prior art keywords
administration
drug delivery
delivery devices
intravaginal drug
oestradiol precursors
Prior art date
Application number
GR990401699T
Other languages
English (en)
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of GR3030614T3 publication Critical patent/GR3030614T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR990401699T 1994-12-19 1999-06-29 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS GR3030614T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05
PCT/IE1995/000063 WO1996019196A1 (en) 1994-12-19 1995-12-19 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS

Publications (1)

Publication Number Publication Date
GR3030614T3 true GR3030614T3 (en) 1999-10-29

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401699T GR3030614T3 (en) 1994-12-19 1999-06-29 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS

Country Status (19)

Country Link
US (1) US5855906A (el)
EP (1) EP0799025B1 (el)
JP (1) JPH10510825A (el)
CN (1) CN1138526C (el)
AR (1) AR002010A1 (el)
AT (1) ATE178204T1 (el)
AU (1) AU692659B2 (el)
CA (1) CA2207622C (el)
DE (1) DE69508791T2 (el)
DK (1) DK0799025T3 (el)
ES (1) ES2133841T3 (el)
FI (1) FI119414B (el)
GR (1) GR3030614T3 (el)
IL (1) IL116433A (el)
NO (1) NO316707B1 (el)
NZ (1) NZ298490A (el)
PE (1) PE62796A1 (el)
TR (1) TR199501599A2 (el)
WO (1) WO1996019196A1 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
PT981327E (pt) * 1997-05-07 2003-02-28 Galen Chemicals Ltd Dispositivos intravaginais de libertacao de farmacos para a administracao de testosterona e percursores da testosterona
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
ES2400091T3 (es) 2005-08-11 2013-04-05 Massachusetts Institute Of Technology Dispositivo de suministro de fármacos intravesical y método
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
EP3566742A1 (en) 2005-10-13 2019-11-13 Synthes GmbH Drug-impregnated encasement
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
WO2008007098A2 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2698143C (en) 2007-06-26 2016-01-19 Warner Chilcott Company, Llc Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
BRPI0917135A2 (pt) * 2008-08-09 2015-11-10 Massachusetts Inst Technology dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica.
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
MX2011013539A (es) 2009-06-26 2012-02-28 Taris Biomedical Inc Tabletas de farmaco solidas para dispositivos implantables para administrar farmacos.
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
CN103917202B (zh) 2011-09-14 2016-06-29 弗赛特影像5股份有限公司 眼插入件装置和方法
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
BR112015022433B1 (pt) 2013-03-15 2022-06-21 Taris Biomedical Llc Dispositivo de liberação de droga intravesical
JP6456935B2 (ja) 2013-06-21 2019-01-23 デピュイ・シンセス・プロダクツ・インコーポレイテッド フィルム及び製造方法
HUE051336T2 (hu) 2013-08-19 2021-03-01 Taris Biomedical Llc Többadagos gyógyszeradagoló eszköz
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CA2944436C (en) * 2014-04-01 2023-08-22 Poly-Med, Inc. Contraceptive and related device
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
EP3285850A1 (en) 2015-04-23 2018-02-28 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
US5855906A (en) 1999-01-05
JPH10510825A (ja) 1998-10-20
AU692659B2 (en) 1998-06-11
ES2133841T3 (es) 1999-09-16
ATE178204T1 (de) 1999-04-15
NZ298490A (en) 1999-11-29
TR199501599A2 (tr) 1996-07-21
FI119414B (fi) 2008-11-14
CA2207622A1 (en) 1996-06-27
IL116433A0 (en) 1996-03-31
DE69508791D1 (de) 1999-05-06
WO1996019196A1 (en) 1996-06-27
NO972798L (no) 1997-08-19
DE69508791T2 (de) 1999-12-02
AR002010A1 (es) 1998-01-07
FI972579A0 (fi) 1997-06-17
NO972798D0 (no) 1997-06-17
EP0799025A1 (en) 1997-10-08
CN1138526C (zh) 2004-02-18
IL116433A (en) 2002-02-10
AU4399196A (en) 1996-07-10
CA2207622C (en) 2006-10-17
NO316707B1 (no) 2004-04-13
FI972579A (fi) 1997-06-17
DK0799025T3 (da) 1999-10-18
PE62796A1 (es) 1996-12-28
CN1170353A (zh) 1998-01-14
EP0799025B1 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
GR3030614T3 (en) INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS
GB2303064B (en) Medicament for nasal administration
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
GB9522403D0 (en) Intravaginal drug delivery device
AU8538991A (en) Delivery device for atomized medicaments
AU5652098A (en) A device for the administration of a liquid medicament suspension
AU1529397A (en) Delivery system for localized administration of medicaments to the upper respiratory tract
GB9016789D0 (en) Medicament administering devices
GB9701904D0 (en) A system for the delivery of drugs and therapeutic agents
HUP9900886A3 (en) Use of bisphosphonates preventing bone loss associated with immunosuppressive therapy for the preparation of pharmaceutical compositions
AU1849988A (en) Drug delivery devices
GB9418064D0 (en) Medicament administration inhaler
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
EP0476711A3 (en) Use of 5-fluorouracil for the treatment of AIDS
ZA975168B (en) Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments
ZA9510787B (en) Intravaginal drug delivery devices for the administration of 17 beta-oestradiol precursors
AU1797592A (en) Vaginal drug delivery device
ZA984832B (en) Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this composition
AU3961693A (en) Compositions and devices for the intrauterine administration of drugs
GB9522402D0 (en) Intravaginal drug delivery device
AU4292993A (en) Improved delivery formulation for lipophilic drugs
SI0808158T1 (en) Medicament form for the delivery of active substances to wounds
GB9713360D0 (en) Intravaginal drug delivery device
GB9724777D0 (en) Intravaginal drug delivery device
GB9017999D0 (en) Device for the administration of pharmacologically active substances